With continuous advancements in cancer treatment, we believe that Oncothermia (mEHT) holds the potential to revolutionize cancer care.
Through recently published, groundbreaking research and presentations, we would like to offer our readers valuable insights into the role of Oncothermia in modern oncology, highlighting its transformative effect on current treatment approaches.
Explore the latest Oncothermia, mEHT publications from Prof. András Szász, the founder of Oncotherm, here:
Szasz, A. (2024)
Preclinical Verification of Modulated Electro-Hyperthermia
— Part I. In Vitro Research
International Journal of Clinical Medicine, 15, 257-298.
Szasz, A. (2024)
Preclinical Verification of Modulated Electro-Hyperthermia
— Part II. In Vivo Research
International Journal of Clinical Medicine , 15, 299-334.
Szasz, A. (2024)
Preclinical Verification of Modulated Electro-Hyperthermia
— Part III. Immunogenic Effects
International Journal of Clinical Medicine , 15, 335-364.
Szasz, A. (2024)
Pulsing Addition to Modulated Electro-Hyperthermia
Bioengineering 2024, 11, 725.
